Info

Five million euros for medical innovation

Press release: Dutch government invests in the pearls of previous research

Eindhoven –  April 23, 2015 – The Dutch Ministry of Economic Affairs has granted 2.5 million euros to extend seven promising research projects aimed at medical innovation. The projects, which are focused at debilitating and life-threatening diseases such as breast cancer, prostate cancer and thrombosis, are part of the Dutch CTMM (Center for Translational Molecular Medicine) research programme. CTMM’s mission is to accelerate the introduction of medical innovations to patients via public-private partnerships collaborations. The companies and academic institutions involved in the seven projects will jointly contribute a matching 2.5 million euros, making a total of 5 million euros available over the next two years.

“Medical innovation takes a long time. We are delighted that the Dutch government is investing in these research pearls,” says Peter Luijten, CTMM Chief Scientific Officer. “Through their support, we can take the last step needed to translate the research results achieved over the last five years into concrete medical applications. This is very good news for patients as well as an important economic boost for the Netherlands.”

All seven research projects are in line with the roadmap of the Dutch Top Sector ‘Life Sciences & Health’ (LSH), one of nine sectors defined by the Dutch government to boost innovation. They are all extensions of previous high-quality research programmes started in 2008 within the CTMM institute.

“In 2008, the Dutch government, along with industry and universities, invested heavily in innovative medical research with the aid of revenue from the Dutch natural gas reserves,” says Luijten. “With today’s additional funding, the government is giving a positive signal that it recognizes the need for long-term investment to capitalize scientific knowledge into medical applications and benefit the whole society.”

Download press release

About the research projects:

1

MARS&MORE

Development of a Point-of-Care test for a rapid and sensitive detection of bloodstream infections

2

VOLTAVALO

Thermal therapies of breast cancer using MRI-guided High Intensity Focused Ultrasound

3

PROCAMOLMED

Validation of two novel molecular markers for prostate cancer

4

CHOICE

Computer-aided prediction of breast cancer therapy response by means of multimodality imaging

5

MICRO-BAT 2014

Microscope-independent thrombus formation to assess bleeding and thrombosis risks
6

ECAF

Development of a Tool for Non-invasive Classification of AF using AF Complexity Analysis of the Esophageal Electrogram
7

deAGEpyr

The effects of pyridoxamine on insulin sensitivity and vascular function; a trial in obese subjects
Output Booklets

If you want to see what 300 million euros of public-private partnership funding can achieve, take a look at the new set of output booklets that have been prepared for the individual CTMM projects.

Scientific breakthroughs, new products, patents, start-up companies, research infrastructures, PhD theses and academic papers, it's all there in black and white - proof that together we have achieved something truly remarkable and placed the Netherlands in a world leading position for translational medical research.

AIRFORCE - personalized chemotherapy against lung cancer

BIOCHIP - Diagnosing leukemia sub-types

Breast CARE - Predicting therapy response in breast cancer patients

DeCoDe - Early diagnosis of colorectal cancer

HIFU-CHEM - More chemo where it should be

MUSIS - Check removal of tumor tissue during surgery

PCMM - Limit over-diagnosis and over-treatment in prostate cancer

VOLTA - Remove tumors through local heating

Circulating Cells - investigating white blood cells and platelets for discriminating patients with increased risk of developing unstable plaques

COHFAR - how to detect and stop ventricular fibrillation by applying a synchronized electrical impulse to heart muscle

Eminence - developing multiple diagnostic technologies to detect neovascularization and stratifying patients

INCOAG - developing a new set of tests to estimate the risk of thrombosis

Parisk - how to predict risk of rupture of an individual plaque

Predicct - focusing on early diagnoses and treatment of Diabetes DM2

Triumph - identifying biomarkers for cardiac failure

LeARN - finding an early diagnosis of Alzheimer's Disease

AmpVacs - a new vaccine technology platform in the combat against conserved influenza A determinants

MARS - tools to provide rapid and accurate information about an individual patient suffering from sepsis

TRACER - patient-tailored treatment of Rheumatoid Arthritis

Health Technology Assessment (HTA)

TraIT - establishing an easy-to-access and easy-to-use infrastructure for sharing of research data, and set of tools for researchers to interact with and explore a unified translational medical research space

March 2018